Background; Recent imaging modality named automated breast ultrasound encountered for mammographic substitution. Aim of our study to compare ABUS and mammography as screening modality with special concern to dense breasts.
Method; Eighty participants from our breast screening program examined with mammography and ABUS. The study was carried out during the period from September 2020 to October 2021.
Results; The percentage of BIRAD II and BIRAD III detected lesions in mammogram was 31.25% and 12.5%, while, in ABUS, it increased to 32.5% and 11.25%, respectively. Also, the percentage of BIRAD IV and BIRAD V detected lesions in mammogram was 20% and 11.25%, while, in ABUS, it increased to 22.5% and 12.5%, respectively; thus, ABUS is a useful tool in detection of benign, probably benign and malignant lesions compared to mammogram. The added value of ABUS over mammography in picking breast lesions was most noted in participants with dense and extremely dense breasts as a statistically significant difference was found. The sensitivity of the ABUS is about 100%, and that means, in all the results of the mammogram study, ABUS can detect it without significant change, while the specificity of the ABUS was about 85%.
Conclusion; ABUS is a scientific improvement in breast radiology with the advantage of innovative diagnostic precision of breast pathologies in terms of initial recognition, better classification, and meticulous evaluation. It is operator independent, saving time, and permits whole breast assessment with no radiation hazard, improved picking of few millimeters' pathologies particularly in dense breast parenchyma.